Shares of SBC Medical Group Holdings Incorporated (NASDAQ:SBC – Get Free Report) saw strong trading volume on Monday following a better than expected earnings announcement. Approximately 198,457 shares traded hands during mid-day trading, an increase of 52% from the average daily volume of 130,815 shares. The stock last traded at $6.5910 and had previously closed at $7.35.
The company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.12 by $0.03. SBC Medical Group had a return on equity of 19.14% and a net margin of 27.26%. The company had revenue of $58.58 million for the quarter, compared to analyst estimates of $48.90 million.
Analyst Ratings Changes
Several brokerages have recently weighed in on SBC. BTIG Research upped their price objective on shares of SBC Medical Group from $8.00 to $10.00 and gave the company a “buy” rating in a report on Friday. Wall Street Zen lowered SBC Medical Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Finally, Weiss Ratings raised SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, SBC Medical Group currently has an average rating of “Moderate Buy” and an average target price of $10.00.
View Our Latest Stock Analysis on SBC
Institutional Trading of SBC Medical Group
Hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in shares of SBC Medical Group during the 2nd quarter valued at about $2,846,000. Russell Investments Group Ltd. grew its stake in shares of SBC Medical Group by 2,810.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 125,991 shares of the company’s stock worth $622,000 after buying an additional 121,662 shares during the last quarter. Marshall Wace LLP bought a new stake in SBC Medical Group during the 3rd quarter valued at about $520,000. Citadel Advisors LLC bought a new stake in SBC Medical Group in the 2nd quarter worth about $446,000. Finally, State Street Corp lifted its holdings in shares of SBC Medical Group by 58.9% during the 3rd quarter. State Street Corp now owns 78,232 shares of the company’s stock valued at $386,000 after buying an additional 28,993 shares during the period. Institutional investors own 60.82% of the company’s stock.
SBC Medical Group Stock Performance
The company has a debt-to-equity ratio of 0.09, a quick ratio of 3.27 and a current ratio of 3.31. The stock has a market cap of $658.22 million, a P/E ratio of 12.84, a P/E/G ratio of 3.30 and a beta of 0.52. The business’s 50-day moving average price is $5.13 and its 200-day moving average price is $3.98.
SBC Medical Group Company Profile
SBC Medical Group Holdings provides management and support services to medical institutions, with a focus on clinics offering aesthetic medicine. Its services include support for clinic operations, marketing, staff training, procurement and customer service, allowing affiliated medical providers to focus on patient care. The group is associated with the Shonan Beauty Clinic brand and a broader network of clinics offering services such as cosmetic surgery and dermatology. Its business is centered primarily in Japan, where it supports the operations and growth of affiliated medical institutions.
Featured Articles
- Five stocks we like better than SBC Medical Group
- Sandisk’s Sell-Off May Be Losing Steam, But the Biggest Risk Still Looms
- Meta’s Access to Capital Remains Strong, But Borrowing Is Becoming More Expensive
- 3 Large-Cap Stocks Are Outperforming the S&P 500 Without AI Hype
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
Receive News & Ratings for SBC Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SBC Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
